Skip to Main Content
Back to News

Lobbying Update: $2,710,000 of PFIZER INC. lobbying was just disclosed

None

$2,710,000 of PFIZER INC. lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Appropriations Inflation Reduction Act (IRA) HR 7174 - Ensuring Pathways to Innovative Cures (EPIC) Act Medicare Price Setting Drug Shortages Global Access to Medicines Trade-Related Aspects of Intellectual Property Rights (IPR) March-in Framework Guidance and Policies S 79/ HR 1717 - Interagency Patent Coordination and Improvement Act of 2023 S 142 - Preserve Access to Affordable Generics and Biosimilars Act HR 6986 - To address patent thickets S 150 - Affordable Prescriptions for Patients Act of 2023 S 2780/ HR 5429 - Medication Affordability and Patent Integrity Act Antimicrobial Resistance PBM Transparency and Reform S 1542 - Delinking Revenue from Unfair Gouging (DRUG) Act S 3430 - Better Mental Health Care, Lower-Cost Drugs and Extenders Act S 2973 - Modernizing and Ensuring PMB Accountability Act 340B Reform HR 8574 - 340B Affording Care for Communities and Ensuring a Strong Safety-net (ACCESS) Act S 723/HR 1458 - Access to Prescription Digital Therapeutics Act HR 8816 - American Medical Innovation and Investment Act of 2024 Comprehensive Corporate Tax Reform Tax Cuts and Jobs Act (TCJA) VICP Reform and Excise Tax Vaccine Injury Compensation Fund VICP Transition Comprehensive Federal Tax Reform International Supply Chain HR 4307/S 2115 - Medical Supply Chain Resiliency Act"

You can find more data on corporate lobbying on Quiver Quantitative.

PFE Congressional Stock Trading

Members of Congress have traded $PFE stock 5 times in the past 6 months. Of those trades, 1 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $PFE stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

PFE Insider Trading Activity

PFE insiders have traded $PFE stock on the open market 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $PFE stock by insiders over the last 6 months:

  • JENNIFER B. DAMICO (SVP & Controller) sold 5,154 shares for an estimated $147,713
  • SCOTT GOTTLIEB purchased 1,000 shares for an estimated $28,240

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

PFE Hedge Fund Activity

We have seen 1,326 institutional investors add shares of PFE stock to their portfolio, and 1,363 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • CAPITAL WORLD INVESTORS removed 34,454,459 shares (-39.1%) from their portfolio in Q3 2024, for an estimated $997,112,043
  • BNP PARIBAS FINANCIAL MARKETS added 14,557,032 shares (+125.5%) to their portfolio in Q3 2024, for an estimated $421,280,506
  • CHARLES SCHWAB INVESTMENT MANAGEMENT INC added 12,864,343 shares (+11.0%) to their portfolio in Q3 2024, for an estimated $372,294,086
  • CITADEL ADVISORS LLC removed 12,333,440 shares (-60.5%) from their portfolio in Q3 2024, for an estimated $356,929,753
  • BARCLAYS PLC added 11,840,905 shares (+77.7%) to their portfolio in Q3 2024, for an estimated $342,675,790
  • BLACKROCK, INC. added 11,623,274 shares (+2.7%) to their portfolio in Q3 2024, for an estimated $336,377,549
  • DEUTSCHE BANK AG\ added 9,809,675 shares (+43.3%) to their portfolio in Q3 2024, for an estimated $283,891,994

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles